Abstract. The retina of the human eye is extremely vulnerable to oxidative damage. Previous studies have demonstrated that oxidative stress is the predominant mechanism associated with the pathogenesis of age-related macular degeneration, diabetic retinopathy, glaucoma and retinitis pigmentosa. MTP-131, a novel mitochondria-targeted peptide, has been demonstrated to specifically concentrate in the inner mitochondria membrane and to exhibit remarkable antioxidant effects both in vitro and in animal models. In the present study, the protective effect of MTP-131 was evaluated in response to hydrogen peroxide (H 2 O 2 )-induced oxidative damage in a retinal ganglion cell line, RGC-5. Cell viability was measured by lactate dehydrogenase (LDH) assay. Changes of mitochondrial membrane potential and generation of intracellular reactive oxygen species (ROS) were measured by flow cytometry and confocal microscopy, respectively. Annexin V-fluorescein isothiocyanate/propidium iodide staining was used for assessment of apoptosis. Release of cytochrome c was analyzed by confocal microscopy. Pretreatment of cells with MTP-131 inhibited H 2 O 2 -induced cytotoxicity and reduced LDH release in a dose-dependent manner, compared with cells treated with H 2 O 2 alone. Mitochondrial depolarization and ROS generation were also prevented by MTP-131 pretreatment. In addition, MTP-131 pretreatment inhibited cytochrome c release from mitochondria to cytoplasm, and significantly reduced apoptosis in RGC-5 cells, compared with cells treated with H 2 O 2 alone. In conclusion, mitochondria-targeted peptide MTP-131 exhibited a protective effect against oxidative stress-induced apoptosis in RGC-5 cells, which may provide a novel approach for the treatment of age-associated retinal diseases.
Introduction
Previous studies have demonstrated the importance of mitochondria and oxidative stress in the development of neuronal diseases, such as Parkinson's disease (PD) and Alzheimer's disease (1, 2) . In human eyes, the retina is extremely vulnerable to oxidative damage. Oxidative stress has been demonstrated to be the predominant mechanism associated with the pathogenesis of age-related macular degeneration (AMD), diabetic retinopathy (DR), glaucoma and retinitis pigmentosa (RP) (3) (4) (5) (6) . Novel strategies targeting mitochondria and reactive oxygen species (ROS) generation may provide promising prospects towards antioxidant therapy in these retinal diseases.
A novel mitochondria-targeted peptide, MTP-131 (also known as SS-31 or Bendavia), originally designed by Hazel H. Szeto and Peter W. Schiller (7) , is a water-soluble peptide with an alternating aromatic cationic motif (D-Arg-dimethylTyr-Lys-Phe-NH 2 ) and a 3+ net charge at physiological pH (8) . The fraction of the peptide partitioned to mitochondria has been estimated to be 1,000 to 5,000-fold compared with the extra-mitochondrial concentration, and the peptide is predominately localized to the inner mitochondrial membrane (7) . MTP-131 reduces ROS production in a dose-dependent manner and prevents oxidative damage in neuronal cell lines (9) . In addition, treatment of mice with MTP-131 prevents loss of neurons and increases survival in PD and amyotrophic lateral sclerosis animal models (10) .
Since MTP-131 has a unique mitochondria-targeted delivery, and exhibits potent antioxidant and neuroprotective effect both in vitro and in vivo, the present study aimed to evaluate the protective effect of MTP-131 against hydrogen peroxide (H 2 O 2 )-induced oxidative damage in RGC-5 cells.
Materials and methods

Reagents and chemicals. MTP-131 (D-Arg-(2'6'-dimethylTyr)-
Lys-Phe-NH 2 ) was kindly provided by Stealth BioTherapeutics, Inc. (Newton, MA, USA). Gibco Dulbecco's modified Eagle's medium (DMEM) and fetal bovine serum (FBS) were obtained from Thermo Fisher Scientific (Waltham, MA, USA). Lactate dehydrogenase (LDH) assay kit was obtained from Roche Diagnostics Gmbh (Mannheim, Germany). Tetramethylrhodamine methyl ester perchlorate (TMRM), 2',7'-dichlorodihydrofluorescein diacetate (H 2 DCFDA) and MitoTracker Deep Red FM were obtained from Thermo Fisher Scientific, Inc. and prepared as 50 µM, 1 and 1 mM stock solutions in dimethyl sulfoxide, respectively. Annexin V-fluorescein isothiocyanate (FITC)/propidium iodide (PI) apoptosis assay kit was from Multisciences Lianke Biotech Co., Ltd. (Hangzhou, China). Unless specified, all other reagents were obtained from Sigma-Aldrich; Merck KGaA (Darmstadt, Germany).
Cell culture. The RGC-5 cell line was kindly provided by Dr Zhiqun Tan (Department of Neurology, UC Irvine School of Medicine, Irvine, CA, USA). Undifferentiated RGC-5 cells were used in the present study. Cells were cultured in DMEM containing 10% FBS, and 1% penicillin-streptomycin (100 U/ml penicillin and 100 µg/ml streptomycin) at 37˚C and 5% CO 2 . Cells were passaged by trypsinization every 3 days. All cell culture dishes and plates were obtained from BD Biosciences (Franklin Lakes, NJ, USA).
MTP-131 pretreatment and induction of oxidative stress.
RGC-5 cells were seeded at a density of 1x10 4 cells/well in 6-well plates and incubated in 5% CO 2 at 37˚C for 24 h. Cells at approximately 70% confluence were pretreated with 0.01, 0.1 or 1 µM MTP-131 in serum-free DMEM at 37˚C for 1 h and then rinsed twice with PBS. Then, RGC-5 cells were exposed to 500 µM H 2 O 2 in serum-free DMEM for 24 h to induce a sustained oxidative stress in vitro. Untreated cells and cells treated with H 2 O 2 alone were used as normal and H 2 O 2 control, respectively.
Measurement of cell viability. Cell viability was assessed by LDH assay using the Cytotoxicity Detection kitPLUS (Roche Diagnostics Gmbh) according to the manufacturer's instructions and as described previously (11) . Briefly, RGC-5 cells were seeded in 96-well plates at a density of 5x10 3 /well, and treated as described above. Culture supernatant (50 µl) from each well was transferred to a new 96-well plate and 100 µl reaction mixture solution was added to each well. Following incubation at room temperature in the dark for 30 min, 50 µl of stop solution was added to each well to terminate the reaction. Absorbance was measured using a microplate reader (Bio-Rad Laboratories, Inc., Hercules, CA, USA), at 490 nm test wavelength and at 630 nm reference wavelength. Cell viability was estimated as follows: cytotoxicity (%) = (experimental value-low control) / (high control-low control) x100%. (ΔΨm) . TMRM, a cationic fluorescent probe which is taken up by mitochondria in a potential-dependent manner, was used to evaluate ΔΨm, as described previously (9 
Measurement of mitochondrial membrane potential changes
Measurement of cytochrome c release.
The release of cytochrome c from mitochondria to the cytoplasm was measured by confocal microscopy as previously described (13) . Briefly, cells were seeded onto Fisherbrand cover glass (Thermo Fisher Scientific, Inc.) at a density of 2,000 cells/chamber. Following pretreatment with 1 µM MTP-131 for 1 h, cells were incubated in the presence or absence of 500 µM H 2 O 2 for 6 h at 37˚C in 5% CO 2 . Freshly prepared MitoTracker (500 nm) was added to the cells and incubated for 30 min, just before the end of the 6 h incubation period. Cells were rinsed twice with PBS and fixed in 4% paraformaldehyde for 15 min, followed by 5 min permeabilization with methanol on ice. Following blocking with 5% bovine serum albumin (BSA, Jackson ImmunoResearch Europe Ltd. Suffolk, UK) for 30 min, cells were incubated with mouse monoclonal anti-cytochrome c antibody (sc-4280; 1:100, diluted with 1% BSA; Santa Cruz Biotechnology, Inc., Dallas, TX, USA) at 4˚C overnight. Following three rinses with PBS, cells were incubated with DyLight 488-conjugated goat anti-mouse immunoglobulin G antibody (85-11-4011-85; 1:500, diluted with 1% BSA; Multisciences Lianke Biotech Co., Ltd.) for 30 min at 37˚C in the dark. Finally, cells were stained with Hoechst 33342 (1:1,000, Thermo Fisher Scientific, Inc.) for 5 min, washed and mounted with anti-fade fluorescence mounting medium (Applygen Technologies, Inc., Beijing, China). Images were visualized by confocal microscopy. Translocation of cytochrome c from mitochondria to cytoplasm was analyzed by overlapping staining of cytochrome c and MitoTracker. In each group, six slides were selected and five fields of view from each were assessed.
Analysis of cell morphology. RGC-5 cells were seeded at a density of 1x10 4 cells/well on a 6-well plate. Following pretreatment with 1 µM MTP-131 for 1 h and subsequent treatment with 500 µM H 2 O 2 for 24 h, micrographs of all cultures were captured using a Zeiss LSM 510 Cell Observer system (Carl Zeiss, AG) to examine changes in cell morphology.
Statistical analysis. All assays were performed in at least three independent experiments and data are presented as the mean + standard error of the mean. Statistical analysis was performed by one-way analysis of variance and Newman-Keuls multiple comparison test, using GraphPad Prism 5.0 software (GraphPad Software Inc., La Jolla, CA, USA). P<0.05 was considered to indicate a statistically significant difference. Fig. 2A, left  panel) , while incubation with 500 µM H 2 O 2 alone for 2 h led to mitochondrial depolarization, resulting in loss of the TMRM dye from the mitochondria and a decrease in fluorescence intensity ( Fig. 2A, middle panel) . Pretreatment of the cells with 1 µM MTP-131 for 1 h, however, inhibited H 2 O 2 -induced mitochondria depolarization, as evidenced by the higher fluorescence intensity of TMRM in the MTP-131-treated cells ( Fig. 2A, right panel) (Fig. 2B and C) . (Fig. 3B and C) .
Results
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MTP-131 treatment protects against H 2 O 2 -induced apoptosis.
Apoptosis was measured by Annexin V-FITC/PI staining and Table I ). Pretreatment with 0.01 µM MTP-131 also alleviated apoptosis at 4 and 8 h following H 2 O 2 incubation, but no effect was observed at 12 and 24 h compared with cells treated with H 2 O 2 alone (Fig. 4 and Table I ).
MTP-131 treatment inhibits H 2 O 2 -induced release of cytochrome c from mitochondria to cytoplasm.
The release of cytochrome c from mitochondria into the cytoplasm was examined by confocal microscopy. As demonstrated in (Fig. 5) . Fig. 6 ).
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Discussion
In the present study, the antioxidant effect of MTP-131 against H 2 O 2 -induced sustained oxidative stress was examined in undifferentiated RGC-5 cells. The present findings demonstrated that MTP-131 treatment prevented mitochondrial depolarization, decreased intracellular ROS production, and inhibited apoptosis induced by sustained oxidative stress in RGC-5 cells.
H 2 O 2 is widely used to induce oxidative stress in experimental studies, leading to an increase in intracellular accumulation of ROS and RGC apoptosis (14) (15) (16) . In the present study, H 2 O 2 (500 µM for 24 h) was used to induce a sustained oxidative stress, and was demonstrated to cause significant cell damage in RGC-5 cells, which is consistent Table I . Summary of flow cytometry data measuring apoptosis. with previous studies (14) . MTP-131 pretreatment protected RGC-5 cells from mitochondrial membrane depolarization, reduced ROS production and inhibited cytochrome c release from mitochondria to cytoplasm. These effects were demonstrated to alleviate apoptosis in RGC-5 cells, thus suggesting that MTP-131 exhibited a potential protective effect against oxidative stress in RGC-5 cells through direct inhibition of mitochondria-mediated pathways.
RGC-5 cells have been widely used in in vitro experimental studies (17) (18) (19) . However, the validity of this cell line is now questioned. It has been demonstrated that the RGC-5 cell line is of mouse origin, not rat as it was first described, and that it express photoreceptor markers instead of retinal ganglion markers (20, 21) . However, RGC-5 cells still have several properties in common with retinal progenitor cells and is therefore appropriate for neuronal cell studies (20) . A series of retinal disorders have been related to oxidative damage, such as AMD, DR and RP (3, 4, 6) . The retina is constantly exposed to visible light, which makes it extremely vulnerable to oxidative damage, due to its great energy demands and high oxygen consumption (5) . A previous study have demonstrated that oxidative stress is extremely important in the retinal pigment epithelium (RPE) cells. ROS induces mitochondrial dysfunction in RPE, leading to RPE cell apoptosis and death of photoreceptor cells (22) .
Compared with traditional antioxidants, MTP-131 represents the only known class of cell-permeable compounds that specifically concentrates in the inner mitochondrial membrane (7) . With a 3+ net charge, MTP-131 selectively binds to cardiolipin and modulates its interaction with cytochrome c. By inhibiting the cytochrome c/cardiolipin complex peroxidase activity, MTP-131 optimizes mitochondrial electron transport and ATP synthesis (23, 24) . Numerous in vitro and animal studies have demonstrated the remarkable efficacy of MTP-131 in age-associated diseases. For example, daily treatment with MTP-131 reverses mitochondrial dysfunction and inhibits neuronal apoptosis and inflammation in mice with sepsis-associated encephalopathy (25) . In addition, MTP-131 exhibits protective effects against cardiac ischemia-reperfusion injury (26) . The effectiveness of cardiolipin combined with MTP-131 is currently being evaluated in a multinational clinical trial for reperfusion injury in patients with acute coronary events (ClinicalTrials.gov Identifier: NCT01572909), and a Phase 2 trial is underway assessing the effectiveness of MTP-131 on improving renal function following angioplasty for severe renal artery stenosis (ClinicalTrials.gov Identifier: NCT01755858) (27) . Since MTP-131 has a unique mitochondria-targeted delivery, and exhibits potent antioxidant and neuroprotective effects both in vitro and in vivo, the present study aimed to evaluate the protective effect of MTP-131 against H 2 O 2 -induced oxidative damage in RGC-5 cells. The present findings demonstrated that MTP-131 inhibited H 2 O 2 -induced mitochondria depolarization, reduced intracellular ROS and prevented apoptosis in RGC-5 cells.
In conclusion, this novel class of targeted peptide therapeutics, including MTP-131, has the potential to restore mitochondrial bioenergetics. Further studies using animal models will be needed in order to fully explore this novel antioxidant approach for the treatment of age-related retinal diseases.
